Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Should You Be Investing In?

Amidst the biotech industry’s rapid growth and notable advancements, let’s analyze which of the two major players, Moderna (MRNA) and BioNTech (BNTX), is a more favorable investment choice in the current uncertain economic climate. Keep reading to find out.

StockNews.com

Uniqure Crashes To Six-Year Low On Muddy Results For Huntington's Gene Therapy

Uniqure unveiled mixed results for its study of a Huntington's disease treatment on Wednesday, and QURE stock crashed to a six-year low.

Investors Business Daily

Drug Stock Poised For Growth With Record Sales, Strong Outlook

Growth stock Intra-Cellular Therapies is finding support at its 21-day moving line with a strong record of impressive sales growth.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Arcellx, A Top 5% Biotech, Dives After A 'Perfect Storm' Leads To A Patient's Death

The FDA placed a study of Arcellx's multiple myeloma drug on hold after a patient died, leading ACLX stock to crumble Tuesday.

Investors Business Daily

AstraZeneca considers spinning off its China business

UK’s largest stock-market-listed firm weighs up Hong Kong or Shanghai listing to shield it from geopolitical tensions

The Guardian - UK

McKesson, IBD Stock Of The Day, Breaks Out Of Lengthy Consolidation, Joins SwingTrader

McKesson is Friday's IBD Stock Of The Day. Drug distributors are benefiting from overall growth in drug sales, helping MCK stock break out.

Investors Business Daily

What CVS stands for throws shoppers as they joke about drugstore's 'government name'

CVS is a household name in the US but finding out in it's an acronym confused many and then finding out what the initials stood for really baffled them

Daily Mirror

Read news from The Economist, FT, and more,
with one subscription

Top 1% Biotech Stock Reata Pharmaceuticals Faces Another Hurdle

Reata took a step closer to launching its highly anticipated Friedreich's ataxia drug on Friday with a new FDA filing, but RETA stock fell.

Investors Business Daily

Inspire Medical Grows Like Gangbusters With Innovative Sleep Apnea Treatment

Inspire Medical stock has been in rally mode after the company reported bullish revenue growth in early May and gave a solid outlook.

Investors Business Daily

Eli Lilly Just Lent Its Big Pharma Cachet To Verve's Nascent Gene-Editing Program For $60 Million

Eli Lilly inked a gene-editing collaboration with Verve Therapeutics that gave the young biotech "pharma validation."

Investors Business Daily

Michael Hiltzik: Merck says it's being 'coerced' into negotiating its drug prices with Medicare. That's nonsense

No one really expected the pharmaceutical industry to lie down and take it when Congress authorized Medicare to start negotiating prices of the prescription drugs it buys for enrollees.

Los Angeles Times

New Zealand seizes 713kg meth hidden in maple syrup from Canada

‘It’s kind of sad in some ways that we keep coming and saying we’re getting bigger and bigger seizures’

The Independent UK

Medtronic weighs appeal after losing patent case regarding catheter technology

MINNEAPOLIS — Medtronic is weighing its next steps after losing another round in a long-running patent dispute with med-tech competitor Teleflex Inc.

Tribune News Service

3 Biotech Stocks With Great Value

The global demand for healthcare and biotech products continues to grow, owing to factors such as increasing chronic diseases and a greater focus on personalized medicine. Therefore, it might be wise to check out fundamentally sound biotech stocks BioMarin Pharmaceutical (BMRN), Exelixis, Inc. (EXEL), and Theratechnologies (THTX), currently trading at…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Axsome Therapeutics Expects Up To $11.5 Billion In Peak Sales, Wallops Analysts' Forecasts

Axsome expects its eight products to generate up to $11.5 billion in peak U.S. sales. AXSM stock zoomed higher Wednesday.

StockNews.com

Tilray Brands (TLRY) vs. Novo Nordisk (NVO): Which Pharma Stock Should You Buy?

The pharmaceutical sector performs relatively well during economic uncertainties due to inelastic demand for its products and services. While prominent players Tilray Brands (TLRY) and Novo Nordisk (NVO) should benefit, which stock is the better buy now? Read more to find out.

Radio France Internationale

Macron promises to bring pharmaceutical production 'back home' to France

French President Emmanuel Macron has vowed to relocate the production of 50 key pharmaceutical drugs, 25 of them - in the coming weeks - to tackle an ongoing shortage of medicines in France.

Investors Business Daily

One Of The Biggest Names In Medicine Just Entered The Obesity Melee. Here's Why Novo, Lilly Still Have An Edge.

Pharma giant Merck unveiled new data for a potential competitor to weight loss drugs from Novo Nordisk and Eli Lilly.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Should You Buy Into Pfizer (PFE) Today?

Despite a slowdown of Covid-19 vaccine sales in the last reported quarter, biopharmaceutical giant Pfizer (PFE) is positioned to deliver robust growth this year and beyond, thanks to the strength of its in-line products and expected near-term launches and revenue distribution from the recent acquisition. So, let’s find out if…

StockNews.com

2 Game-Changing Biotech Stocks, 1 to Sell Now

As the biotech industry looks well-positioned for solid growth driven by strong government support and a growing foothold of personalized medicines, it could be wise for investors to buy fundamentally strong biotech stocks Gilead Sciences (GILD) and Regeneron Pharmaceuticals (REGN). However, fundamentally weak Titan Pharmaceuticals (TTNP) might be best avoided.…

Birmingham Post

Pharma firm Quantum sees big increase in revenues and profits

The County Durham company said it was focussed on growth after a successful year

StockNews.com

Is Catalyst Pharmaceuticals (CPRX) a Buy in the Near Future?

Catalyst Pharmaceuticals (CPRX) witnessed significant bottom-line growth in the first quarter but missed expectations. Does the biopharmaceutical company deserve a place in your portfolio in the near future? Let’s look at its financial metrics to get an idea….

Newsroom.co.nz

Advocating for climate justice

As part of a weekly showcase of future leaders and inspirational young New Zealanders from the Hyundai Pinnacle Programme, Isla Day wants to develop better connections between industry and academia in the field of drug development – and fight for climate justice | Content Partnership

Investors Business Daily

Biogen Rises After 'Drama-Free' Panel Votes Unanimously In Support Of Alzheimer's Drug

Biogen stock rose Monday after a panel of advisors to the FDA voted unanimously in favor of its newest Alzheimer's treatment.

Investors Business Daily

Why Perfectly Rated Disc Medicine, With A 287% Move This Year, Just Put Up Another Big Gain

Disc Medicine said Friday its drug improved symptoms for patients with sunlight intolerance. The highly rated biotech stock soared.

1 … 35 36 37 38

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Australian Federal Police

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.